Zyprexa side effects were not disclosed to the FDA
According to a New York Times article today, Eli Lilly provided incorrect and misleading information to the FDA regarding Zyprexa side effects back in February 2000. Federal regulators are reviewing whether actions will be taken against the drug maker for their deception. In addition, the company is facing investigations regarding their marketing and promotional practices, as well as thousands of lawsuits and class action claims.
>>INFORMATION: Zyprexa lawsuits
Data submitted by Eli Lilly in 2000 indicated that Zyprexa had little or no effect on blood sugar levels, while the real data from clinical trials demonstrated that those taking Zyprexa were three and a half times more likely to develop high blood sugar, also known as hyperglycemia.
Eli Lilly was aware that clinical trials demonstrated that 3.6 percent of those who took Zyprexa experienced high blood sugar, compared with only 1.1 percent for those who took a sugar pill. Eli Lilly claims that they found the errors when they rechecked their original statistics, but at the time the data was submitted to the FDA they indicated that the figures had already been checked
Eli Lilly’s failure to provide accurate data is especially troubling since high blood sugar can lead to diabetes if it goes untreated. Diabetes is a very serious condition which effects the body’s ability to regulate blood sugars, and it is one of the leading causes of death in the United States.
Both consumers and the FDA relied on Eli Lilly to be honest about Zyprexa side effects. The federal drug oversight agency generally does not perform detailed audits of clinical trials which drug manufacturers send to them, as they do not have the resources to double check all data.
Zyprexa is an atypical antipsychotic approved for treatment of schizophrenia. Additional uses include treatment of anxiety, obsessive compulsive disorders and autism. Zyprexa side effects have been linked to an increased risk of:
- Hyperglycemia (high blood sugar)
- Diabetes
- Pancreatitis
- Ketoacidosis (diabetic coma)
- Tardive dyskinesia
ZYPREXA LAWSUITS
Zyprexa lawsuits have been filed against the manufacturer for failing to warn about the risks associated with the drug. The company has already settled approximately 28,500 lawsuits for about $1.2 billion, and at least 1,200 lawsuits are still pending. The Zyprexa lawyers at Saiontz & Kirk, P.A. are still reviewing and investigating new claims for users who suffered serious injuries. However, time may be running out to pursue a claim. To speak with an attorney, request a free claim evaluation.
